Johnson & Johnson FDA Clears OTTAVA Robotic Surgical System
NEW BRUNSWICK, N.J., July 22, 2026 Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NEW BRUNSWICK, N.J., July 22, 2026 Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has...
SEOUL, South Korea, June 18, 2026 MediThinQ, a leading innovator in digital surgical visualization technologies, has entered into an...
UPPSALA, Sweden, June 1, 2026 Senzime AB announced the commercial launch of its next-generation TetraSens® electromyography (EMG) sensor, designed...
UPPSALA, Sweden, May 27, 2026 Senzime AB announced that the U.S. Food and Drug Administration has granted an additional...
